首页 › 基金 › Washington Trust Advisors, Inc. › AXSM
Washington Trust Advisors, Inc. 对 AXSM 的持仓历史
AXSOME THERAPEUTICS INC. · 医疗保健
Washington Trust Advisors, Inc. 在 Q3 2026 的 13F 申报中披露持有 AXSM(AXSOME THERAPEUTICS INC.)43,963 股,市值约 US$8.1M,约占其申报组合的 0.58%,在其申报持仓中市值排名第 43 位。 Washington Trust Advisors, Inc. 最近 12 个申报季度中有 12 个季度披露了 AXSM 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Washington Trust Advisors, Inc. 对 AXSM 的持仓演变
Washington Trust Advisors, Inc. 于 Q4 2023 首次披露 AXSM 持仓:330 股(约 US$26K)。 该持仓在 Q3 2026 达到峰值 43,963 股,市值约 US$8.1M。 在 12 次申报中,Washington Trust Advisors, Inc. 1 次增持、2 次减持、8 次保持不变。 最近一期申报(Q3 2026)显示持股 43,963 股、市值约 US$8.1M,环比增持 43,788 股。。 持仓曾出现大幅变动:Q2 2026 减持约 30% (随后一个季度股价下跌 25%)、Q3 2026 增持约 25022% (随后一个季度股价下跌 23%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 330 | $26.27K | 新进 |
| Q1 2024 | 330 | $26.33K | 持有 |
| Q2 2024 | 330 | $26.57K | 持有 |
| Q3 2024 | 330 | $29.66K | 持有 |
| Q4 2024 | 330 | $27.92K | 持有 |
| Q1 2025 | 250 | $29.16K | 减持 |
| Q2 2025 | 250 | $26.10K | 持有 |
| Q3 2025 | 250 | $30.36K | 持有 |
| Q4 2025 | 250 | $45.66K | 持有 |
| Q1 2026 | 250 | $42.26K | 持有 |
| Q2 2026 | 175 | $42.84K | 减持 |
| Q3 2026 | 43.96K | $8.11M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AXSM 与 13F 数据
AXSM(AXSOME THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 AXSM,申报仓位最大的包括:Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Hood River Capital Management LLC (US$98.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AXSM 的基金
- Deep Track Capital, LP 700.00K 股 · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 649.12K 股 · $119.69M · Q3 2026
- Hood River Capital Management LLC 402.68K 股 · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K 股 · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K 股 · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K 股 · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K 股 · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K 股 · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K 股 · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K 股 · $53.46M · Q2 2026
- Cannell & Spears LLC 259.65K 股 · $47.88M · Q3 2026
更多关于 Washington Trust Advisors, Inc.
常见问题
How long has Washington Trust Advisors, Inc. held AXSM?
Washington Trust Advisors, Inc. has disclosed AXSM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Washington Trust Advisors, Inc.'s current position in AXSM?
As of Q3 2026, Washington Trust Advisors, Inc. holds 43.96K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $8.11M, representing 0.58% of its reported portfolio and ranking #43.
Has Washington Trust Advisors, Inc. been buying or selling AXSM?
In the latest 13F filing (Q3 2026), Washington Trust Advisors, Inc. increased its position in AXSM. The position peaked in Q3 2026 at 43.96K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.